/VOR

VOR

VOR

$22.30USD↓-0.18%-0.04 today

MARKET CAP

1.3B

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$22 – $23

52W RANGE

$7

$50

AI Summary

Stalk

StalkMedium

VOR remains in a Stage 2 advancing structure with active Momentum Breakout and higher highs & lows confirming bullish continuation, but given the speculative strategy and price extended above rising EMAs, execution is deferred until a pullback into the 24.1–25.1 support zone for a clear entry.

↑Advancing telitacicept in global Phase 3 trials for myasthenia gravis and Sjögren’s
↑$491.5 M capital reserve supports late‐stage clinical development
↓Negative earnings yield and poor profitability raise sustainability concerns

Full analysis →

Buying

7

institutions

Selling

3

institutions

New Positions

3

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	3.47 M	63.85 M	+2.67 M	+350.3%	0.00%
RC Ra Capital Management, L.P. Q2 2026	SELL	2.40 M	44.22 M	+-3.00 M	-54.1%	0.38%
AC Adar1 Capital Management, LLC Q2 2026	BUYNEW	680.63 K	12.53 M	+680.63 K	+0.0%	0.58%
MM Millennium Management LLC Q2 2026	BUY	428.07 K	7.88 M	+169.48 K	+70.8%	0.00%
WP Woodline Partners LP Q2 2026	BUYNEW	379.72 K	6.99 M	+379.72 K	+0.0%	0.02%
CA Citadel Advisors LLC Q2 2026	BUY	160.41 K	2.95 M	+11.65 K	+11.3%	0.00%
EP Eversept Partners, LP Q2 2026	BUYNEW	149.68 K	2.76 M	+149.68 K	+0.0%	0.14%
RT Renaissance Technologies LLC Q2 2026	SELL	33.01 K	607.73 K	+-95.83 K	-73.6%	0.00%
JC Jpmorgan Chase & Co Q2 2026	BUY	21.62 K	402.15 K	+17.26 K	+526.9%	0.00%
BH Brevan Howard Capital Management LP Q2 2026	SELL	0.00	0.00	+-42.22 K	-100.0%	0.00%